For over twelve years, ArunA Biomedical has manufactured and provided neural stem cells to the world’s leading research organizations with unrivaled uniformity and scale.

Today, we are translating this expertise into a new class of cell-free biologics, exosomes, for the treatment of CNS and neurodegenerative disorders with an initial focus in stroke and creating a platform to empower efficiencies in drug delivery for our partners.

To date, our exosomes have demonstrated the ability to:

  • Reduce inflammation and enhance neural function

  • Cross the blood brain barrier to reach site of injury

  • Enable multiple intravenous (IV) dosing without adverse response

  • Treatment greatly reduces hemorrhaging within 24 hours post-injury.

To learn more about the therapeutic potential of our exosomes and programs, click here.

To learn how exosomes can solve your drug delivery problems, click here.